Healthcare - Biotechnology - NASDAQ - US
$ 0.5497
-7.16 %
$ 93.6 M
Market Cap
-0.46
P/E
BALANCE SHEET
359 M
ASSETS
403 M
LIABILITIES
-44.9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Seres Therapeutics, Inc.
| Current Assets | 175 M |
| Cash & Short-Term Investments | 128 M |
| Receivables | 8.67 M |
| Other Current Assets | 38.8 M |
| Non-Current Assets | 183 M |
| Long-Term Investments | 0 |
| PP&E | 132 M |
| Other Non-Current Assets | 50.9 M |
| Current Liabilities | 98.7 M |
| Accounts Payable | 3.64 M |
| Short-Term Debt | 13.4 M |
| Other Current Liabilities | 81.7 M |
| Non-Current Liabilities | 305 M |
| Long-Term Debt | 207 M |
| Other Non-Current Liabilities | 97.5 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Cash & Cash Equivalents | 128.0 | 163.0 | 180.0 | 116.0 | 65.1 | 85.8 | 36.1 | 54.5 | 73.9 | 114.2 | 1.7 | 6.2 |
| Short Term Investments | 0 | 18.3 | 110.7 | 137.6 | 29.7 | 0 | 113.9 | 138.7 | 131.1 | 0 | 0 | 0 |
| Receivables | 8.7 | 0 | 0 | 9.4 | 1.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 29.6 | 0 | 0 | 1 | (29.7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 9.1 | 13.4 | 25.8 | 11.5 | 3.6 | 13.7 | 5.1 | 5.1 | 2.5 | 58 K | 51 K | 30 K |
| Total Current Assets | 175.4 | 194.8 | 303.6 | 268.8 | 100.2 | 92.7 | 155.1 | 198.4 | 207.6 | 114.2 | 1.7 | 6.2 |
| PP&E | 132.2 | 134.0 | 36.1 | 22.9 | 30.9 | 26.3 | 32.9 | 36.1 | 7.8 | 1.3 | 0.4 | 0.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 9.6 | 0.5 | 49.8 | 1.4 | 1.4 | 1.5 | 36.8 | 1.5 | 0 | 0 | 0 |
| Other Long Term Assets | 50.9 | 10.5 | 14.6 | 1.4 | 0 | 0.1 | 0 | 1.4 | 0 | 1.8 | 68 K | (0.3) |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 K |
| Total Assets | 358.6 | 348.8 | 354.9 | 342.9 | 132.4 | 120.5 | 189.5 | 272.6 | 216.9 | 117.3 | 2.1 | 6.5 |
| LIABILITIES | ||||||||||||
| Accounts Payable | 3.6 | 17.4 | 13.7 | 4.0 | 4.9 | 6.4 | 7.0 | 7.6 | 5.4 | 2.2 | 0.4 | 0.1 |
| Short Term Debt | 13.4 | 4.1 | 13.2 | 5.6 | 8.9 | 0 | 0 | 0 | 0 | 1.2 | 0.4 | 0 |
| Other Current Liabilities | 73.9 | 105.0 | 38.5 | 21.7 | 8.2 | 15.2 | 12.5 | 10.8 | 5.5 | 1.7 | 0.3 | 66 K |
| Total Current Liabilities | 98.7 | 85.6 | 82.3 | 46.4 | 46.0 | 42.0 | 31.6 | 30.5 | 10.9 | 5.1 | 1.1 | 0.2 |
| Long Term Debt | 207.3 | 158.5 | 42.6 | 35.2 | 40.3 | 0 | 0 | 0 | 0 | 1.3 | 0.4 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | (5.0) | (6.8) | (10.7) | 0 | 0 | 0 | 0 |
| Other Liabilities | 2.2 | 1.4 | 11.5 | 1.0 | 0.5 | 9.6 | 12.4 | 12.8 | 0.6 | 137.7 | 11.7 | 0 |
| Total Liabilities | 403.5 | 338.0 | 223.4 | 168.2 | 180.8 | 168.5 | 128.8 | 140.0 | 11.5 | 144.1 | 13.2 | 0.2 |
| EQUITY | ||||||||||||
| Common Stock | 0.1 | 0.1 | 92 K | 91 K | 70 K | 41 K | 40 K | 40 K | 39 K | 7 K | 7 K | 7 K |
| Retained Earnings | (978.2) | (864.5) | (614.4) | (548.8) | (459.6) | (389.4) | (263.6) | (174.2) | (82.6) | (27.8) | (11.1) | (4.4) |
| Other Accumulative Comprehensive Income/Loss | 0 | 12 K | 60 K | 47 K | 0 | (20.3) | (0.1) | (0.1) | 30 K | (137.7) | 0 | 0 |
| Total Equity | (44.9) | 10.8 | 131.5 | 174.8 | (48.3) | (48.0) | 60.7 | 132.6 | 205.4 | (26.7) | (11.1) | 6.4 |
| Total Liabilities and Equity | 358.6 | 348.8 | 354.9 | 342.9 | 132.4 | 120.5 | 189.5 | 272.6 | 216.9 | 117.3 | 2.1 | 0 |
| SHARES OUTSTANDING | ||||||||||||
| Common Shares Outstanding | 128.0 | 108.1 | 91.7 | 79.8 | 56.6 | 40.7 | 40.4 | 39.8 | 23.5 | 29.8 | 29.8 | 20.7 |